ENTRY       D11959                      Drug
NAME        Praluzatamab (USAN/INN)
FORMULA     C6942H10740N1828O2176S48
EXACT_MASS  156065.2537
MOL_WEIGHT  156161.617
SEQUENCE    (Heavy chain)
            QITLKESGPT LVKPTQTLTL TCTFSGFSLS TYGMGVGWIR QPPGKALEWL ANIWWSEDKH
            YSPSLKSRLT ITKDTSKNQV VLTITNVDPV DTATYYCVQI DYGNDYAFTY WGQGTLVTVS
            SASTKGPSVF PLAPSSKSTS GGTAALGCLV KDYFPEPVTV SWNSGALTSG VHTFPAVLQS
            SGLYSLSSVV TVPSSSLGTQ TYICNVNHKP SNTKVDKKVE PKSCDKTHTC PPCPAPELLG
            GPSVFLFPPK PKDTLMISRT PEVTCVVVDV SHEDPEVKFN WYVDGVEVHN AKTKPREEQY
            NSTYRVVSVL TVLHQDWLNG KEYKCKVSNK ALPAPIEKTI SKAKGQPREP QVYTLPPSRE
            EMTKNQVSLT CLVKGFYPSD IAVEWESNGQ PENNYKTTPP VLDSDGSFFL YSKLTVDKSR
            WQQGNVFSCS VMHEALHNHY TQKSLSLSPG
            (Light chain)
            QGQSGQGLCH PAVLSAWESC SSGGGSSGGS AVGLLAPPGG LSGRSDNHGG SDIVMTQSPL
            SLPVTPGEPA SISCRSSKSL LHSNGITYLY WYLQKPGQSP QLLIYQMSNL ASGVPDRFSG
            SGSGTDFTLK ISRVEAEDVG VYYCAQNLEL PYTFGQGTKL EIKRTVAAPS VFIFPPSDEQ
            LKSGTASVVC LLNNFYPREA KVQWKVDNAL QSGNSQESVT EQDSKDSTYS LSSTLTLSKA
            DYEKHKVYAC EVTHQGLSSP VTKSFNRGEC
            (Disulfide bridge: H22-H97, H148-H204, H224-L270, H230-H'230, H233-H'233, H265-H325, H371-H429, H'22-H'97, H'148-H'204, H'224-L'270, H'265-H'325, H'371-H'429, L9-L20, L74-L144, L190-L250, L'9-L'20, L'74-L'144, L'190-L'250)
  TYPE      Peptide
EFFICACY    Antineoplastic, Anti-CD166 antibocy
  TYPE      Monoclonal antibody
TARGET      ALCAM (CD166) [HSA:214] [KO:K06547]
  PATHWAY   hsa04514(214)  Cell adhesion molecules
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                ALCAM (CD166)
                 D11959  Praluzatamab (USAN/INN)
DBLINKS     CAS: 2145109-70-0
///
